PurposeTo evaluate the real-world diagnostic performance of high-resolution susceptibility-weighted imaging (HR-SWI) and investigate whether the reader's predictions can be used to find cases where HR-SWI finding and final clinical diagnosis matched.MethodsThis retrospective study enrolled patients with suspected Parkinsonism (n = 48) or volunteers with other intracranial pathologies (n = 31) who underwent brain magnetic resonance imaging (MRI) including HR-SWI, which was used to evaluate nigrosome 1 (NG1). All patients with suspected Parkinsonism underwent N-3-fluoropropyl-2-carbomethoxy-3-4-iodophenyl nortropane (FP-CIT) positron emission tomography and a clinical diagnosis was made by a neurologist. The HR-SWI data were qualitatively ana...
Objectives This study aimed to compare susceptibility map-weighted imaging (SMwI) using various MRI ...
Introduction: Parkinson’s disease (PD) is the most common movement disorder in the elderly and is ch...
Contains fulltext : 154047.pdf (publisher's version ) (Closed access)BACKGROUND AN...
Background and Purpose Susceptibility-weighted imaging (SWI) of nigrosome-1 is an emerging and clini...
Background and Purpose Susceptibility-weighted imaging (SWI) of nigrosome-1 is an emerging and clini...
Background and Purpose Susceptibility-weighted imaging (SWI) of nigrosome-1 is an emerging and clini...
Background and Purpose Susceptibility-weighted imaging (SWI) of nigrosome-1 is an emerging and clini...
BACKGROUND: Previous case-control studies have suggested that the absence of a swallow-tail appearan...
BACKGROUND: Previous case-control studies have suggested that the absence of a swallow-tail appearan...
There is no well-established in vivo marker of nigral degeneration in Parkinson’s disease (PD). An i...
<div><p>There is no well-established <i>in vivo</i> marker of nigral degeneration in Parkinson's dis...
There is no well-established in vivo marker of nigral degeneration in Parkinson's disease (PD). An i...
BACKGROUND AND PURPOSE: The differentiation between Parkinson disease and atypical parkinsonian synd...
Contains fulltext : 167533.pdf (publisher's version ) (Open Access)BACKGROUND: Pre...
Objective: Automatize the detection of ‘swallow-tail’ appearance in substantia nigra dopaminergic ne...
Objectives This study aimed to compare susceptibility map-weighted imaging (SMwI) using various MRI ...
Introduction: Parkinson’s disease (PD) is the most common movement disorder in the elderly and is ch...
Contains fulltext : 154047.pdf (publisher's version ) (Closed access)BACKGROUND AN...
Background and Purpose Susceptibility-weighted imaging (SWI) of nigrosome-1 is an emerging and clini...
Background and Purpose Susceptibility-weighted imaging (SWI) of nigrosome-1 is an emerging and clini...
Background and Purpose Susceptibility-weighted imaging (SWI) of nigrosome-1 is an emerging and clini...
Background and Purpose Susceptibility-weighted imaging (SWI) of nigrosome-1 is an emerging and clini...
BACKGROUND: Previous case-control studies have suggested that the absence of a swallow-tail appearan...
BACKGROUND: Previous case-control studies have suggested that the absence of a swallow-tail appearan...
There is no well-established in vivo marker of nigral degeneration in Parkinson’s disease (PD). An i...
<div><p>There is no well-established <i>in vivo</i> marker of nigral degeneration in Parkinson's dis...
There is no well-established in vivo marker of nigral degeneration in Parkinson's disease (PD). An i...
BACKGROUND AND PURPOSE: The differentiation between Parkinson disease and atypical parkinsonian synd...
Contains fulltext : 167533.pdf (publisher's version ) (Open Access)BACKGROUND: Pre...
Objective: Automatize the detection of ‘swallow-tail’ appearance in substantia nigra dopaminergic ne...
Objectives This study aimed to compare susceptibility map-weighted imaging (SMwI) using various MRI ...
Introduction: Parkinson’s disease (PD) is the most common movement disorder in the elderly and is ch...
Contains fulltext : 154047.pdf (publisher's version ) (Closed access)BACKGROUND AN...